MSc(Res) Translational Oncology

Lead academic: Dr Helen Bryant

Translational oncology is the process by which laboratory cancer research informs the development of new treatments for cancer. It’s a rapidly advancing field with massive therapeutic and commercial potential, and recent graduates have gone on to work in academic research science, pharmaceuticals, medical writing, the biotech industry and the NHS among others.

Our MSc(Res) is taught by leading research scientists and clinicians. The course offers training in cancer biology / treatment theory and practice of translational oncology and provides you with transferable skills for your future career.

The course is designed so that students progressively achieve more advanced levels of learning and practice by giving a thorough grounding in the subject matter through five taught modules before leading you into the advanced research modules, namely the literature review and the six-month research project, for which you’ll work as part of a team within the oncology research community at Sheffield.

Translational oncology / cancer research in Sheffield is well-established, spanning several faculties and departments. We hold Experimental Cancer Medicine Centre (ECMC) status in recognition of our clinical trials expertise, so you'll study in a world-class research environment with a multidisciplinary research team of basic and clinical scientists.

We'll give you the opportunity to experience cancer research at all stages of drug discovery and development, from fundamental research to molecular mechanisms and their implementation in new cancer therapies and offer career development tutorials, including CV writing, career tracking and critical appraisal.

Book a 15-minute online meeting with our course tutor to find out more information and ask further questions.

Read more
£29,950 Per Year

International student tuition fee

1 Year

Duration

Sep 2024

Start Month

Aug 2024

Application Deadline

Upcoming Intakes

  • September 2024

Mode of Study

  • Full Time